Legal & General Group’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-147,302
| Closed | -$589K | – | 3373 |
|
|
2019
Q4 | $589K | Buy |
147,302
+9,513
| +7% | +$44.7K | ﹤0.01% | 2192 |
|
|
2019
Q3 | $676K | Sell |
137,789
-4,009
| -3% | -$22.4K | ﹤0.01% | 2108 |
|
|
2019
Q2 | $864K | Sell |
141,798
-2,180
| -2% | -$11.6K | ﹤0.01% | 1999 |
|
|
2019
Q1 | $837K | Buy |
143,978
+12,614
| +10% | +$130K | ﹤0.01% | 2019 |
|
|
2018
Q4 | $1.79M | Buy |
131,364
+213
| +0.2% | +$3.59K | ﹤0.01% | 1638 |
|
|
2018
Q3 | $2.54M | Buy |
131,151
+24,177
| +23% | +$515K | ﹤0.01% | 1585 |
|
|
2018
Q2 | $2.75M | Buy |
106,974
+6,877
| +7% | +$160K | ﹤0.01% | 1497 |
|
|
2018
Q1 | $2.03M | Buy |
100,097
+2,264
| +2% | +$52.8K | ﹤0.01% | 1608 |
|
|
2017
Q4 | $1.97M | Buy |
97,833
+5,562
| +6% | +$109K | ﹤0.01% | 1628 |
|
|
2017
Q3 | $1.91M | Buy |
92,271
+6,800
| +8% | +$115K | ﹤0.01% | 1611 |
|
|
2017
Q2 | $1.26M | Buy |
85,471
+6,964
| +9% | +$116K | ﹤0.01% | 1749 |
|
|
2017
Q1 | $1.25M | Buy |
78,507
+1,275
| +2% | +$18.4K | ﹤0.01% | 1715 |
|
|
2016
Q4 | $974K | Buy |
77,232
+36,187
| +88% | +$674K | ﹤0.01% | 1749 |
|
|
2016
Q3 | $1.14M | Buy |
41,045
+32,062
| +357% | +$1.08M | ﹤0.01% | 1341 |
|
|
2016
Q2 | $312K | Buy |
8,983
+954
| +12% | +$30K | ﹤0.01% | 1593 |
|
|
2016
Q1 | $222K | Buy |
8,029
+625
| +8% | +$18.4K | ﹤0.01% | 1703 |
|
|
2015
Q4 | $254K | Buy |
7,404
+1,152
| +18% | +$35.9K | ﹤0.01% | 1647 |
|
|
2015
Q3 | $178K | Buy |
6,252
+1,165
| +23% | +$49.8K | ﹤0.01% | 1759 |
|
|
2015
Q2 | $227K | Buy |
5,087
+2,286
| +82% | +$86K | ﹤0.01% | 1691 |
|
|
2015
Q1 | $97K | Buy |
2,801
+2,284
| +442% | +$62.2K | ﹤0.01% | 2064 |
|
|
2014
Q4 | $14K | Buy |
+517
| New | +$12.5K | ﹤0.01% | 2648 |
|
Other funds holding DPLO
Legal & General Group's DPLO Position: Q1 2020 in Review
Legal & General Group sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 147,302 shares — an estimated $589K sold.
Legal & General Group first reported a position in DPLO in Q4 2014 and held it in 21 quarters. The position peaked at $2.75M in Q2 2018. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.
- Legal & General Group reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
- Legal & General Group sold 147,302 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $589K.
- Legal & General Group first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and held it in 21 quarters.
- Legal & General Group's DIPLOMAT PHARMACY, INC. position peaked at $2.75M in Q2 2018.
- 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.
Based on Legal & General Group's 13F filing for Q1 2020, filed 14 May 2020.